- Home
- RVPH vs PD Comparison
RVPH vs PD Comparison
Compare RVPH & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- PD
- Stock Information
- Founded
- RVPH 2006
- PD 2009
- Country
- RVPH United States
- PD United States
- Employees
- RVPH N/A
- PD N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- PD Computer Software: Prepackaged Software
- Sector
- RVPH Health Care
- PD Technology
- Exchange
- RVPH Nasdaq
- PD Nasdaq
- Market Cap
- RVPH 32.8M
- PD 1.4B
- IPO Year
- RVPH N/A
- PD 2019
- Fundamental
- Price
- RVPH $0.39
- PD $15.72
- Analyst Decision
- RVPH Strong Buy
- PD Buy
- Analyst Count
- RVPH 5
- PD 12
- Target Price
- RVPH $9.00
- PD $19.50
- AVG Volume (30 Days)
- RVPH 2.5M
- PD 1.5M
- Earning Date
- RVPH 08-13-2025
- PD 09-02-2025
- Dividend Yield
- RVPH N/A
- PD N/A
- EPS Growth
- RVPH N/A
- PD N/A
- EPS
- RVPH N/A
- PD N/A
- Revenue
- RVPH N/A
- PD $476,132,000.00
- Revenue This Year
- RVPH N/A
- PD $9.60
- Revenue Next Year
- RVPH N/A
- PD $7.56
- P/E Ratio
- RVPH N/A
- PD N/A
- Revenue Growth
- RVPH N/A
- PD 8.55
- 52 Week Low
- RVPH $0.30
- PD $13.70
- 52 Week High
- RVPH $4.28
- PD $23.03
- Technical
- Relative Strength Index (RSI)
- RVPH 31.05
- PD 56.91
- Support Level
- RVPH $0.30
- PD $15.09
- Resistance Level
- RVPH $0.83
- PD $16.49
- Average True Range (ATR)
- RVPH 0.07
- PD 0.46
- MACD
- RVPH -0.04
- PD 0.17
- Stochastic Oscillator
- RVPH 16.04
- PD 95.74
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About PD PagerDuty Inc.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.